Showing results (2451-2460 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|March 2, 2006
Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label studyJonathan M Meyer, Gahan Pandina, Cynthia A Bossie, et al.Clinical Therapeutics|March 2, 2006
A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgeryEffie L Gillespie, C Michael White, Jeffrey Kluger, et al.Clinical Therapeutics|February 24, 2006
Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual functionMartin Miner, Matt T Rosenberg, Michael A PerelmanClinical Therapeutics|February 24, 2006
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week studyRobert A Nathan, Anthony Rooklin, Lynne Schoaf, et al.Clinical Therapeutics|February 24, 2006
Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe painSharon M Weinstein, Minggao Shi, Barbara J Buckley, et al.Clinical Therapeutics|November 29, 2007
Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims dataChristopher Owens, Brooke Pugmire, Ty Salness, et al.Clinical Therapeutics|December 1, 2007
Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparisonLiza L Ilag, Lisa Kerr, James K Malone, et al.Clinical Therapeutics|December 1, 2007
Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in medicaid-enrolled patients with type 2 diabetes mellitusRajesh Balkrishnan, Bhakti V Arondekar, Fabian T Camacho, et al.Clinical Therapeutics|January 23, 1999
Realizing the promise of the US Food and Drug Administration Modernization ActR L WolgemuthClinical Therapeutics|January 23, 1999
Balancing risks versus benefits in drug therapy decisionsL LasagnaPageof 680